Skip to content
ClinCalc Pro
Menu
Magnesium salt / bronchodilator / antiarrhythmic

Magnesium Sulphate IV (Additional Indications)

Brand names: Magnesium Sulphate Injection

Intravenous magnesium sulphate used for additional emergency indications beyond eclampsia, including severe acute asthma as adjunctive therapy and certain unstable ventricular arrhythmias such as torsades de pointes.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

Given intravenously, magnesium acts as a calcium antagonist and membrane stabiliser, relaxing bronchial and vascular smooth muscle and suppressing triggered cardiac activity that drives torsades.

Prescribing in practice

  • Magnesium toxicity (loss of reflexes, respiratory depression, hypotension) is the principal danger, so monitor clinically and keep intravenous calcium available as the antidote.
  • Lower the dose and monitor more intensively in renal impairment, where magnesium accumulates rapidly.
  • Control the infusion rate, as rapid intravenous administration can precipitate flushing, hypotension and bradycardia.

Monitoring

Monitor reflexes, respiratory rate, blood pressure, cardiac rhythm and urine output during infusion, with serum magnesium levels in renal impairment or repeated dosing.

Counselling the patient

  • Flushing or a feeling of warmth during the drip is common and usually settles quickly.
  • Alert staff immediately if you feel weak, very drowsy or short of breath.

Evidence & guidelines

Intravenous magnesium as adjunct in severe asthma and for torsades de pointes is supported by national asthma guidance and resuscitation council recommendations.

Reference: BTS/SIGN Asthma Guideline 2023; Resuscitation Council TdP Algorithm; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.

📚 MRCEM Revision

Featured in these MRCEM clinical pathways

Magnesium Sulphate IV (Additional Indications) is a core drug in the following exam-focused workups on our sister siteReviseMRCEM.

MRCEM Primary / Intermediate / OSCE candidates: each pathway includes exam-style questions, RCEM/NICE citations, and FAQ summaries.